A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
Month: June 2025
SPONSORED CONTENT
AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just marketing is getting blurrier by the day.
We’ve seen AI do
…
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Align charge capture and 340B strategy to unlock long-term sustainability.
In today’s margin-pressured environment, 340B savings
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
For the third straight time in 2025, a federal audit has found a drug manufacturer overcharged covered entities for 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …